Azithrocin® contains Azithromycin U.S.P. It is an azalide antibiotics active against Gram-positive and gram negative organisms. Azithrocin®
(Azithromycin) in indicated for infections caused by susceptible
organisms; In lower respiratory tract infections including bronchitis
and pneumonia, skin and soft tissue infections, otitis media and in
upper respiratory tract infections including sinusitis, pharyngitis and
tonsillitis. In sexually transmitted disease in men and women Azithrocin® (Azithromycin) is indicated in the treatment of uncomplicated genital infections due to Chlamydia trachomatis. Azithrocin® has very simple once daily dosage schedule for 3 days only, which is very convenient for the patients.Azithrocin 250 Tab..
What Viracin® is and what it is used for?Ribavirin,
is a nucleoside analogue with antiviral activity and inhibits HCV
polymerase in a biochemical reaction. It is used in the treatment of
Hepatitis C with othet antiviral drugs.Before you take Viracin® Do not take this medicine and tell your doctor if:
Pregnant. Viracin® may cause fetal harm when administered to a pregnant woman. Viracin® is contraindicated in women who are or may become pregnant.Have hemoglobinopathies (e.g., thalassemia major or sickle-cell anemia).In combination with didanosine. Reports of fatal hepatic failure, as
well as peripheral neuropathy, pancreatitis and symptomatic
hyperlactatemia/lactic acidosis have been reported in clinical trials.
Check with your doctor before taking this medicine if:Birth
defects and fetal death with ribavirin: Do not use in pregnancy and for
6 months after treatment. Patients must have a negative pregnancy test
prior to therapy, use at least 2 forms of contraception and undergo
monthly pregnancy tests. For a male patient, it is very important for
his female partner to avoid becoming pregnant during treatment and
during the 7 months after treatment and do not have sex with a pregnant
Taking other medicines
Nucleoside reverse transcriptase inhibitors or reduce dose or
discontinue interferon, ribavirin or both with worsening toxicitiesAzathioprine: Concomitant use of azathioprine with ribavirin has
been reported to induce severe pancytopenia and may increase the risk of
Pregnancy and breast-feedingCategory
X. Ribavirin produced significant embryocidal and/or teratogenic
effects in all animal species in which adequate studies have been
conducted. Malformations of the skull, palate, eye, jaw, limbs, skeleton
and gastrointestinal tract were noted. It is not known whether
Ribavirin is excreted in human milk. Because many drugs are excreted in
human milk and to avoid any potential for serious adverse reactions in
nursing infants from ribavirin, a decision should be made either to
discontinue nursing or therapy with Viracin®, based on the importance of the therapy to the mother.
How to take Viracin®?Taking this medicine Always use Viracin® exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.
How much to takeDosage of Viracin®
is weight based (<75 kg = 1000 mg and >75 kg = 1200 mg). The
daily dosage of Ribavirin is administered orally in two divided doses
If you take more Viracin than you shouldIf
you remember the missed dose that same day, take the medication right
away. However, if you do not remember the missed dose until the next
day, call your doctor to find out what to do. Do not take a double dose
to make up for a missed one.
If you stop taking Viracin ((Do not need to change))Your
doctor may decrease your dose or tell you to stop taking ribavirin if
you develop side effects of the medication or if certain laboratory
tests show that your condition has not improved.
Possible side effects Like all medicines, Viracin can cause side effects, although not everybody gets them.The
most common adverse reactions in adults receiving combination therapy
are psychiatric and central nervous system effects, severe ocular
disorder, dental and periodontal disorders & growth inhibition in
children and adolescents that may be irreversible in some patients. The
most common adverse reactions in pediatric subjects were similar to
those seen in adults.
Tell your doctor if any of the
side effects gets serious or lasts longer than a few days, or if you
notice any side effects not listed in this leaflet
How to store Viracin® 60 MR?Keep out of the reach of children. Keep in a cool & dry place. Protect from light.
Viracin® Prescribing InformationLocated in: Anti-infectives..
IndicationsRheumatoid Arthritis (RA): Tocilizumab is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more Disease-Modifying Anti-Rheumatic Drugs (DMARDs).Giant Cell Arteritis (GCA): Tocilizumab is indicated for the treatment of giant cell arteritis (GCA) in adult patients.Polyarticular Juvenile Idiopathic Arthritis (PJIA): Tocilizumab is indicated for the treatment of active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older.Systemic Juvenile Idiopathic Arthritis (SJIA): Tocilizumab is indicated for the treatment of active systemic juvenile idiopathic arthritis in patients 2 years of age and older.Cytokine Release Syndrome (CRS): Tocilizumab is indicated for the treatment of chimeric antigen receptor (CAR) T cell-induced severe or life-threatening cytokine release syndrome in adults and pediatric patients 2 years of age and older.* চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুনTherapeutic ClassDrugs used for Rheumatoid ArthritisPharmacologyTocilizumab is a recombinant humanized anti-human interleukin 6 (IL 6) receptor monoclonal antibody of the immunoglobulin (Ig) IgG1 subclass. Tocilizumab binds specifically to both soluble and membrane-bound IL 6 receptors (sIL 6R and mIL 6R), and has been shown to inhibit sIL 6R and mIL 6R-mediated signaling. Interleukin-6 is a multi-functional cytokine, produced by a variety of cell types involved in local paracrine function as well as regulation of systemic physiological and pathological processes eg, induction of immunoglobulin secretion, T-cell activation, induction of hepatic acute phase proteins and stimulation of haematopoiesis. Interleukin-6 has been implicated in the pathogenesis of diseases including inflammatory diseases, osteoporosis and neoplasia. The possibility exists for tocilizumab to affect host defences against infections and malignancies. The role of IL-6 receptor inhibition in the development of malignancies is not known.Dosage & AdministrationGeneral (IV or SC Injection): Substitution by any other biological medicinal product requires the consent of the prescribing physician.For adult patients with RA, tocilizumab may be administered as an IV infusion or a SC injection. For patients with pJIA and sJIA, tocilizumab is administered as an IV infusion.Tocilizumab IV formulation should be diluted by a healthcare professional with sterile 0.9% w/v sodium chloride solution using aseptic technique (see Caution for Usage).Tocilizumab is recommended for IV infusion over 1 hr.Tocilizumab SC formulation is administered with a single-use PFS+NSD or pre-filled pen. The 1st injection should be performed under the supervision of a qualified healthcare professional. The recommended injection sites (abdomen, thigh and upper arm) should be rotated and injections should never be given into moles, scars or areas where the skin is tender, bruised, red, hard or not intact.SC Injection: Adults: Rheumatoid Arthritis (RA): Recommended Dose: 162 mg given once every week as a SC injection. Tocilizumab can be used alone or in combination with MTX and/or other DMARDs.Patients transitioning from tocilizumab IV therapy to SC administration should administer the 1st SC dose at the time of the next scheduled IV dose under the supervision of a qualified healthcare professional.Tocilizumab SC formulation is not intended for IV administration. Assess suitability of patient for SC home use and instruct patients to inform a healthcare professional if they experience symptoms of allergic reaction before administering the next dose. Patients should seek immediate medical attention if developing symptoms of serious allergic reactions* চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুনInteractionInteractions with Other Medicinal Products and Other Forms of Interaction: Population pharmacokinetic analyses did not detect any effect of MTX, nonsteroidal anti-inflammatory drugs or corticosteroids on tocilizumab clearance.Concomitant administration of a single dose of 10 mg/kg tocilizumab with 10-25 mg MTX once weekly had no clinically significant effect on MTX exposure.Tocilizumab has not been studied in combination with other biological DMARDs.The expression of hepatic CYP450 enzymes is suppressed by cytokines, eg, IL-6, that stimulate chronic inflammation. Thus, CYP450 expression may be reversed when potent cytokine inhibitory therapy, eg, tocilizumab is introduced.In vitro studies with cultured human hepatocytes demonstrated that IL-6 caused a reduction in CYP1A2, CYP2C9, CYP2C19 and CYP3A4 enzyme expression. Tocilizumab normalizes expression of these enzymes. The effect of tocilizumab on CYP enzymes (except CYP2C19 and CYP2D6) is clinically relevant for CYP450 substrates with a narrow therapeutic index and/or where the dose is individually adjusted.In a study in RA patients, levels of simvastatin (CYP3A4) were decreased by 57% one week following a single dose of tociliz..
Remdesivir has an FDA Emergency Use Authorization for use in adults and children with suspected or confirmed COVID-19 in hospital with an oxygen saturation ≤ 94%* চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুনTherapeutic ClassAnti-viral drugsDescriptionRemdesivir, or GS-5734, is an adenosine triphosphate analog first described in the literature in 2016 as a potential treatment for Ebola. In 2017, its activity against the coronavirus family of viruses was also demonstrated. Remdesivir is also being researched as a potential treatment to SARS-CoV-2, the coronavirus responsible for COVID-19. Remdesivir was granted an FDA Emergency Use Authorization on 1 May 2020. This is not the same as an FDA approval.PharmacologyRemdesivir is a nucleoside analog that is expected to inhibit the action of RNA polymerase. By incorporating into RNA, additional nucleotides cannot be added, terminating RNA transcription. Viruses with mutations in RNA polymerase to develop partial resistance to remdesivir have been shown to be less infective.Dosage & AdministrationThe FDA Emergency Use Authorization suggests a loading dose of 200 mg once daily in patients ≥ 40 kg or 5 mg/kg once daily in patients 3.5 kg to less than 40 kg, followed by a maintenance dose of 100 mg once daily in patients ≥ 40 kg or 2.5 mg/kg once daily in patients 3.5 kg to less than 40 kg. Patients not needing invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO) should be treated for 5 days (including the loading dose on day 1), up to 10 days if they do not show improvement. Patients requiring invasive mechanical ventilation or ECMO should be treated for 10 days.Clinical trials used a regimen of 200mg once daily on the first day, followed by 100mg once daily for another 9 days. Early data suggests that some patients may benefit from only 5 days of treatment.Remdesivir was originally investigated as a treatment for Ebola virus, but has potential to treat a variety of RNA viruses. Its activity against the coronavirus (CoV) family of viruses, such as SARS-CoV and MERS-CoV, was described in 2017, and it is also being investigated as a potential treatment for SARS-CoV-2 infections.* চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুনContraindicationsRemdesivir is contraindicated in patients with known hypersensitivity to any ingredient of remdesivir.Side EffectsAn adverse reaction associated with remdesivir in clinical trials in healthy adult subjects was increased liver transaminases. Additional adverse reactions associated with the drug, some of which may be serious, may become apparent with more widespread use.Pregnancy & LactationRemdesivir should be used during pregnancy only if the potential benefit justifies the potential risk for the mother and the fetus.PrecautionsThere are limited clinical data available for remdesivir. Serious and unexpected adverse events may occur that have not been previously reported with remdesivir use.Use in Special PopulationThe pharmacokinetics of remdesivir have not been evaluated in patients with renal impairment. The pharmacokinetics of remdesivir have not been evaluated in patients with hepatic impairment. It is not known if dosage adjustment is needed in patients with hepatic impairment and remdesivir should only be used in patients with hepatic impairment if the potential benefit outweighs the potential risk.Storage ConditionsStore diluted remdesivir solution for infusion up to 4 hours at room temperature (20°C to 25°C) or 24 hours at refrigerated temperature (2°C to 8°C).Prior to dilution, equilibrate remdesivir injection to room temperature (20°C to 25°C). Sealed vials can be stored up to 12 hours at room temperature prior to dilution...
IndicationsStrongyloidiasis of the intestinal tract: Ivermectin is indicated for the treatment of intestinal (i.e., nondisseminated) strongyloidiasis due to the nematode parasite Strongyloides stercoralis. This indication is based on clinical studies of both comparative and open-label designs, in which 64-100% of infected patients were cured following a single 200-mcg/kg dose of ivermectin.Onchocerciasis: Ivermectin is indicated for the treatment of onchocerciasis due to the nematode parasite Onchocerca volvulus. This indication is based on randomized, double-blind, placebo-controlled and comparative studies conducted in 1427 patients in onchocerciasis-endemic areas of West Africa. The comparative studies used diethylcarbamazine citrate (DEC-C).* চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুনTherapeutic ClassAnthelminticPharmacologyIvermectin selectively binds and with high affinity to glutamate-gated chloride ion channels, which occur in invertebrate nerve and muscle cells leading to an increase in the permeability of cell membranes to chloride ions with hyperpolarization of the nerve or muscle cell and, ultimately, death of the parasite.DosageStrongyloidiasis: A single oral dose designed to provide approximately 200 mcg of Ivermectin / kg of body weight on an empty stomach with water.Dosage Guidelines for Ivermectin for Strongyloidiasis:Body Weight (kg) 15-24: Dose 3 mg/kgBody Weight (kg) 25-35: Dose 6 mg/kgBody Weight (kg) 36-50: Dose 9 mg/kgBody Weight (kg) 51-65: Dose 12 mg/kgBody Weight (kg) 66-79: Dose 15 mg/kgBody Weight (kg) >80: Dose 200 mcg/kgOnchocerciasis: The recommended dosage of Ivermectin is a single oral dose designed to provide approximately 150 mcg of Ivermectin per kg of body weight on an empty stomach with water, the most commonly used dose interval is 12 months. For the treatment of individual patients, retreatment may be considered at intervals as short as 3 months.Dosage Guidelines for Ivermectin for Onchocerciasis:Body Weight (kg) 15-25: Dose 3 mg/kgBody Weight (kg) 26-44: Dose 6 mg/kgBody Weight (kg) 45-64: Dose 9 mg/kgBody Weight (kg) 65-84: Dose 12 mg/kgBody Weight (kg) >85: Dose 150 mcg/kg..
1. What Kovicin® is and what it is used forKovicin® is the preparation of Hydroxychloroquine sulfate that works by reducing inflammation in people with autoimmune diseases (this is where the body’s immune system attacks itself by mistake).It can be used for:Rheumatoid arthritis (inflammation of the joints)Juvenile idiopathic arthritis (in children)Discoid and systemic lupus erythematosus (a disease of the skin or the internal organs)Skin problems which are sensitive to sunlightEmergency use for COVID 19 patients in hospital settingsMalaria2. Do not take hydroxychloroquine sulfate if:You are allergic (hypersensitive) to:HydroxychloroquineOther similar medicines such as quinolones and quinineAny of the other ingredients of hydroxychloroquine sulfateSigns of allergic reaction include: a rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue.You have an eye problem which affects the retina, the inside of the eye (maculopathy) or you get a change in eye colour or any other eye problem.Cardiac arrhythmiaDo not take this medicine if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking hydroxychloroquine sulfate.3. How to take hydroxychloroquine sulfateAlways take hydroxychloroquine sulfate exactly as your doctor has told you. You should discuss with your doctor if you are not sure.4. Possible side effectsLike all medicines, hydroxychloroquine sulfate can cause side effects, although not everybody gets them. Common side effects include; Corneal changes eg, oedema & opacities, haloes, blurred vision, photophobia; skin rashes, pigmentary skin & mucous membrane changes, hair bleaching, alopecia; nausea, diarrhoea, anorexia, abdominal pain; skeletal muscle myopathy or neuromyopathy; anaemia, aplastic anaemia, agranulocytosis, decreased WBC, thrombocytopenia; urticaria, angioedema, bronchospasm.ContraindicationsCardiac arrhythmia, Hypersensitivity to hydroxychloroquine or 4-aminoquinoline compound, Pre-existing eye maculopathy and Pregnancy.Special PrecautionsSensitivity to quinine. Discontinue use if pigmentary abnormality, visual field defect, unexplainable abnormalities by difficulty in accommodation or presence of corneal opacities, visual disturbances including abnormal colour vision develops; anaemia, aplastic anaemia, agranulocytosis, decreased WBC & thrombocytopenia occur.Pregnancy and breast-feedingUse of this medicine is not recommended during pregnancy. If you discover that you are pregnant or are planning to have a baby, consult your doctor right away to re-assess the need for treatment.Do not take hydroxychloroquine sulfate if you are breast-feeding or planning to breast-feed. This is because small amounts may pass into mother’s milk. Ask your doctor or pharmacist for advice before taking any medicine if you are pregnant or breast-feeding..
Product details of Omron HEM 7120 Automatic Blood Pressure Monitor
Simple one touch operation
LCD size (LxW) 59mm x 43mm
Weight (without battery): approx. 250g
Battery life: 1000 times (4 x AA batteries)
Arm Cuff: Fit arm circumference (22-32cm)
Display: Systolic Blood Pressure, Diastolic Blood Pressure, Pulse Display
5 Years Warranty from Manufacturer (Omron)
OMRON HEM-7120 is a trusted brand automated blood pressure monitor whichpromises accuracy, comfort and ease of use. Simple one touch operation
LCD size (LxW) 59mm x 43mm
Weight (without battery): approx. 250g
Battery life: 1000 times (4 x AA batteries)
Arm Cuff: Fit arm circumference (22-32cm)
Display: Systolic Blood Pressure, Diastolic Blood Pressure, Pulse Display SpecificationsWeight:0.8 KgColor:White Type:Blood Pressure Monitorbattery:4 x 1.5V AA size alkaline batteriesDisplay:Liquid Crystal DisplayPower:4 pices AA SIze Battry,DC ADATER 6v..
Omron NE-C101 makes managing your respiratory health easy. It's simple to use, efficient, ensuring quick and reliable treatment for you and your loved ones.SpecificationUser-friendly Administers medication at the touch of a buttonEfficient Nebulization Rate of 0.3ml/minSmall Particle Size of MMAD 3.9µm to reach lower airway for effective nebulization12ml Medication CapacityComplete accessories including nebulizer kit, adult and child mask, mouthpiece, nosepiece, air tube, spare air filters and quick start guide..
Pulse Oximeter Linte MedProduct parametersDisplay mode：true color high resolution OLED displayBlood oxygen saturation measurement range：36～99%Accuracy：±2（70%～100%），＜70%undefinedPulse rate：30bpm～250bpmPower：2×1.5V 7alkaline batteryWorking current：30mA～80mAWeight：about 54g(without battery)Size：about 70mmX35mmX34mmBluetooth function：optionalDescription：The nail oximeter is small in size, low in power consumption, easy to use, and easy to carry. As long as the finger is inserted into the finger-type photoelectric sensor, the device collects the data through a light-sensitive detector and then displays the measurement on the indicator. Clinical trials have shown high accuracy and repeatability. The nail oximeter can also be used to measure heartbeat, and its function is also very good.Audible alarmHigh precision, accurate measurementAnti-wet perfusion and exerciseDisplay value in 10 seconds, true color high resolution OLED displayLow power consumptionManual four-way displayDisplay oxygen saturation, pulse rate, histogram and waveformWith battery level displayReminderCompact and lightweight, easy to operate and carryAutomatic shuithin 10 seconds..
1. What VIRAFLU is and what it is used forVIRAFLU is the preparation of favipiravir in a tablet form. Favipiravir is a modified pyrazine analog that was initially approved for therapeutic use in resistant cases of influenza.Uses:Novel or re-emerging influenza virus infections (limited to cases in which other anti-influenza virus agents are not effective or insufficiently effective).2. Precautions:VIRAFLU is a drug the use of which is considered only when there is an outbreak of novel or re-emerging influenza virus infections in which other anti-influenza virus agents are not effective or insufficiently effective, and the government decides to use the drug as a countermeasure against such influenza viruses. When administering the drug, obtain the latest information including the government's direction of countermeasures against such influenza viruses, and prescribe only to appropriate patients.3. Possible side effects:Major adverse reactions included increase of blood uric acid level (4.79%), diarrhoea (4.79%), decrease of neutrophil count (1.80%), increase of AST (GOT) (1.80%), increase of ALT (GPT) (1.60%).4. Special population:Use in the Elderly:Since the elderly often have reduced physiological functions, VIRAFLU should be administered with care to them by monitoring their general conditions.Use during Pregnancy and Lactation:Do not administer VIRAFLU to women known or suspected to be pregnant.When administering VIRAFLU to lactating women, instruct to stop lactating.Pediatric Use:VIRAFLU has not been administered to children.5. How to take VIRAFLU:Always take the medicine exactly as your doctor prescribed.The usual dosage of favipiravir for adults is 1600 mg orally twice daily for 1 day followed by 600 mg orally twice daily for 4 days. The total administration period should be 5 days...